Request a Call Back
Back to: Onivyde Post-Launch HCP Website
Brand: Onivyde (irinotecan liposome), Injection
Parent Company: Ipsen
Drug Type: Boxed Warning
Drug Category: Oncology
Campaign: Post-Launch
Targeting: HCPs
Patient Website:
HCP Website: https://www.onivyde.com/
Parent Company: Ipsen
Drug Type: Boxed Warning
Drug Category: Oncology
Campaign: Post-Launch
Targeting: HCPs
Patient Website:
HCP Website: https://www.onivyde.com/